- $96.56bn
- $97.94bn
- $10.21bn
- 64
- 51
- 75
- 70
Annual balance sheet for CME, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,734 | 2,950 | 2,816 | 3,024 | 3,006 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 461 | 435 | 483 | 536 | 573 |
| Total Other Current Assets | |||||
| Total Current Assets | 89,284 | 161,762 | 139,078 | 94,890 | 103,034 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,058 | 931 | 838 | 744 | 672 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 124,660 | 196,780 | 174,176 | 129,706 | 137,447 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 88,198 | 160,398 | 137,688 | 93,417 | 102,314 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 98,340 | 169,381 | 147,297 | 102,968 | 110,960 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 26,320 | 27,399 | 26,879 | 26,738 | 26,487 |
| Total Liabilities & Shareholders' Equity | 124,660 | 196,780 | 174,176 | 129,706 | 137,447 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |